SmartHarvest's Strategic Buys
SmartHarvest Portfolios Increases Major Holdings in QQQ, AbbVie, UnitedHealth, and McDonald’s
Anonymous
Key Points
1
For Invesco QQQ, hedge funds and other institutional investors own 44.58% of the fund, and the article notes QQQ opened at $717.12 with a 1-year range of $523.65 to $748.65 (50-day SMA $678.17; 200-day SMA $634.57).
2
For AbbVie, SmartHarvest’s AbbVie stake is described as 0.8% of its holdings and its 18th biggest position, while the article says hedge funds and other institutional investors own 70.23% of AbbVie; it also highlights Norges Bank’s $5.865 billion “new position” purchase in the quarter.
3
For UnitedHealth Group, the article specifies that institutional investors own 87.86% and provides the exact analyst target changes and dates cited: UBS raised its price target from $410 to $460 (buy) on May 22; Jefferies increased $340 to $373 (buy) on April 20; and Morgan Stanley lifted $395 to $453 (overweight) on June 4.
4
For McDonald’s, beyond SmartHarvest’s purchase, the SEC-related report notes insider selling: EVP Desiree Ralls-Morrison sold 2,763 shares at an average price of $278.36 for a total of $769,108.68, a 30.59% decrease in her position (transaction dated May 28).
5
For McDonald’s, the article also details other concurrent institutional activity—e.g., Brighton Jones LLC increased its position by 21.6%, reaching 9,286 shares worth $2.692 million after acquiring an additional 1,649 shares in the fourth quarter.
SmartHarvest Portfolios LLC has snapped up new or expanded stakes in four major U.S. holdings — Invesco QQQ, AbbVie, UnitedHealth Group, and McDonald's — according to recent regulatory filings MarketBeat. The purchases range from roughly $819,000 in McDonald's to $2.3 million in AbbVie, signaling a broad bet on both tech-heavy growth and defensive blue-chip names.
The moves come as institutional investors rotate back into U.S. equities. AbbVie alone saw Norway's sovereign wealth fund, Norges Bank, enter a staggering $5.865 billion new position in the same period MarketBeat.
SmartHarvest Loads Up on QQQ and AbbVie
SmartHarvest added 1,394 shares of Invesco QQQ, the popular Nasdaq-100 ETF. The fund opened at $717.12 on June 11, sitting well above its 200-day moving average of $634.57 Investing.com. Institutional investors own 44.58% of QQQ. Some technical analysts flag short-term "Sell" signals, warning that QQQ has dipped from its June 2 all-time high of $746.16 Financhill.
In AbbVie, SmartHarvest bought roughly 9,927 shares worth about $2.3 million. That makes AbbVie the firm's 18th biggest holding, at 0.8% of its total portfolio MarketBeat. Institutions now own 70.23% of AbbVie. Analysts point to the drugs Skyrizi and Rinvoq as key growth drivers, replacing revenue lost after Humira's patent expired.
Analyst Targets for UnitedHealth Keep Climbing
SmartHarvest purchased 2,854 shares of UnitedHealth Group for roughly $942,000 tickerreport.com. Institutional investors own a massive 87.86% of the company — the highest among SmartHarvest's four new positions. Three major Wall Street firms have raised their price targets in recent weeks.
UBS lifted its target from $410 to $460 (Buy) on May 22. Morgan Stanley raised its target from $395 to $453 (Overweight) on June 4. Jefferies increased its target from $340 to $373 (Buy) back on April 20 GuruFocus. UBS analysts estimate UNH trades at a roughly 35% discount to its intrinsic value of around $605. Still, analyst targets range from $287 to $492 — an unusually wide $205 spread — reflecting real uncertainty around DOJ antitrust probes and future Medicare payment changes.
McDonald's AI Push Meets Executive Stock Sale
SmartHarvest bought about 2,679 McDonald's shares for roughly $819,000. The purchase coincides with a major technology push at the company. On June 8, McDonald's confirmed it is testing "Archy," a Google-backed AI drive-thru system, at five locations Newsweek. Early Chicago-area tests have reportedly handled over 1 million transactions, targeting 90% order accuracy.
Not everyone is bullish, however. On May 28, McDonald's EVP and Chief Legal Officer Desiree Ralls-Morrison sold 2,763 shares at an average price of $278.36, collecting $769,108.68 and cutting her direct stake by 30.59% Investing.com. Brighton Jones LLC moved the other direction, boosting its McDonald's position by 21.6% to 9,286 shares worth $2.692 million after buying an additional 1,649 shares MarketBeat.
Defensive Bets and the Road Ahead
The heavy buying in healthcare — UnitedHealth and AbbVie together — points to a defensive tilt. Even as SmartHarvest bets on QQQ's tech growth, its largest single purchase by share count is in pharma. Institutions appear to believe that essential services will hold their margins even if the Nasdaq rally slows.
The next major test comes on July 27, 2026, when UnitedHealth reports Q2 earnings TheStreet. A repeat of Q1's Medical Care Ratio of 83.9% — meaning the company spends less than 84 cents of every premium dollar on claims — would likely push Wall Street to raise targets even further. For McDonald's, the success or failure of the "Archy" AI rollout will determine whether the company's tech pivot justifies current institutional enthusiasm.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
18
Articles
19
Reach
37
A
AnonymousAuthor
